Valuation Marker Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 08/05/2026 BST			5-day change	1st Jan Change
1.460 ^USD	+1.39%		0.00%	-2.01%

03-18	Marker Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-17	Marker Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	78.94	22.71	48.89	33.3	24.84	24.34	-	-
Change	-	-71.23%	115.29%	-31.89%	-25.4%	-2.01%	-	-
Enterprise Value (EV)	78.94	22.71	48.89	33.3	24.84	24.34	24.34	24.34
Change	-	-71.23%	115.29%	-31.89%	-25.4%	-2.01%	0%	0%
P/E ratio	-1.73x	-0.74x	-	-2.61x	-1.89x	-1.47x	-1.44x	3x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-	-	0.1x	-0.1x	-0.61x	-0x
Capitalization / Revenue	63.6x	2.52x	-	5.05x	7x	9.03x	1.21x	0.29x
EV / Revenue	0x	0x	-	0x	0x	9.03x	1.21x	0.29x
EV / EBITDA	-	-	-	-0x	-0x	-1.61x	-1.53x	3.26x
EV / EBIT	-0x	-	-	-0x	-0x	-1.22x	-1.09x	1.45x
EV / FCF	-0x	-	-	-	-0x	-2.39x	-1.25x	-1x
FCF Yield	-38.5%	-	-	-	-48.4%	-41.9%	-79.7%	-100%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-5.5	-3.58	-	-1.19	-0.79	-0.9933	-1.017	0.4867
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1.242	9.014	-	6.591	3.547	2.695	20.05	83.84
EBITDA ¹	-	-	-	-11.12	-12.89	-15.11	-15.89	7.466
EBIT ¹	-39.48	-	-	-11.12	-12.89	-19.97	-22.33	16.74
Net income ¹	-41.88	-	-8.237	-10.73	-12.16	-19.54	-19.92	14.78
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	9.502	2.659	5.500	3.110	1.490	1.460	1.460	1.460
Nbr of stocks (in thousands)	8,308	8,540	8,889	10,707	16,673	16,673	-	-
Announcement Date	17/03/22	22/03/23	25/03/24	31/03/25	18/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MARKER THERAPEUTICS, INC.	-1.47x	-	-	-	24.34M
LONZA GROUP AG	29.29x	5.17x	16.01x	1.11%	43.39B
BEONE MEDICINES AG	47.3x	4.79x	31.64x	-.--%	34.7B
REVOLUTION MEDICINES, INC.	-17.93x	275.37x	-16.05x	-.--%	30.15B
IQVIA HOLDINGS INC.	21.76x	2.53x	10.94x	-.--%	29.83B
CELLTRION, INC.	31.98x	8.16x	20.99x	0.39%	28.46B
IONIS PHARMACEUTICALS, INC.	-21.32x	13.76x	-21.38x	-.--%	12.51B
EUROFINS SCIENTIFIC SE	20.79x	1.84x	8.08x	1.29%	12.29B
Average	13.80x	44.52x	7.17x	0.4%	23.92B
Weighted average by Cap.	20.48x	48.06x	10.79x	0.39%